Drug · DIN 02495422
FLEXERIL
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 5, 2023; first marketed March 20, 2020.
- Drug Identification Number (DIN)
- 02495422
- Company (DIN owner)
- Orimed Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Cyclobenzaprine M03BX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 7, 2020: NOC 23085Abbreviated New Drug Submission (ANDS) · New labelling and administrative licensing agreement between two companies